AI-Powered Digital Twins Give Clinical Trials a 75-Year Upgrade
6:08
A new wave of generative AI and digital twin technology could be poised to upend the $100 billion clinical trial industry.
Related Videos
In Monday Conversation
-
Play video FIS Says Risk Negotiation at the Point of Sale Is New Merchant-Issuer Model
FIS Says Risk Negotiation at the Point of Sale Is New Merchant-Issuer Model
Jim Johnson of FIS says the Kipp-powered model flips “declined” debit messages into instant approvals. Don’t miss this conversation.
7:40
-
Play video Clip: AI-Powered Digital Twins Give Clinical Trials a 75-Year Upgrade
Clip: AI-Powered Digital Twins Give Clinical Trials a 75-Year Upgrade
A new wave of generative AI and digital twin technology could be poised to upend the $100 billion clinical trial industry.
0:21
-
Play video Live | Monday Conversation | Currency.com | Konstantin Anissimov
Live | Monday Conversation | Currency.com | Konstantin Anissimov
23:04
-
Play video AI-Powered Digital Twins Give Clinical Trials a 75-Year Upgrade
AI-Powered Digital Twins Give Clinical Trials a 75-Year Upgrade
A new wave of generative AI and digital twin technology could be poised to upend the $100 billion clinical trial industry.
23:34
-
Play video FIS Says Risk Negotiation at the Point of Sale Is New Merchant-Issuer Model
FIS Says Risk Negotiation at the Point of Sale Is New Merchant-Issuer Model
Jim Johnson of FIS says the Kipp-powered model flips “declined” debit messages into instant approvals. Don’t miss this conversation.
21:05
-
Play video Expedia's Private-Label Push Turns Loyalty Points Into Economic Leverage
Expedia's Private-Label Push Turns Loyalty Points Into Economic Leverage
Inflation and tariff anxieties aside, business must go on. It's a message that's finding traction at Expedia. It's tapping into consumers' growing appetite for personalized rewards programs, driving double-digit growth in its B2B private-label busine
23:41
